Ƶ

Earlier Info on Financial Stress; Obesity and Second Cancers; Carcinogenic Condoms?

— News, features, and commentary about cancer-related issues

Last Updated September 20, 2024
Ƶ MedicalToday
Onco Break over a computer rendering of a cancer cell.

Patients with cancer want information and advice early in the disease course about how to deal with the of their costly care. (Northwestern University)

The FDA to include combination therapy with pemetrexed and cisplatin for previously untreated advanced/metastatic malignant pleural mesothelioma, Merck announced.

The agency also for use with pemetrexed and carboplatin in previously treated non-small cell lung cancer with EGFR exon 19 deletions or exon 21 L858R substitution mutations.

Patients who are overweight or obese at cancer diagnosis have an increased risk of developing , according to a study of older cancer survivors. (JAMA Network Open)

A novel three-drug regimen led to an 80% response rate in a small study of patients with . (University of Texas MD Anderson Cancer Center, The Lancet Haematology)

A phase III trial of the antibody-drug conjugate patritumab deruxtecan in non-small cell lung cancer met the , although two deaths not directly attributed to the drug were reported, Merck and Daiichi Sankyo announced.

Oncternal Therapeutics announced of a clinical trial of the androgen receptor inhibitor ONCT-534 in metastatic castration resistant prostate cancer and its ONCT-808 CAR T-cell program in lymphoma and plans to "explore strategic alternatives."

Ultimovacs ASA announced in a clinical trial of a cancer vaccine for non-small cell lung cancer.

Bipartisan legislation introduced in the Senate seeks to curb on social media. (The Hill)

A proposed class action lawsuit alleges that contain toxic "forever chemicals," which have been linked to cancer. (Reuters)

Ossium Health announced a first successful stem-cell transplant for leukemia involving .

Higher state- and county-level had a significant association with cancer mortality. (American Cancer Society, Journal of the National Cancer Institute)

The FDA issued draft guidance to industry on considerations for the design and conduct of of cancer treatment in support of drug-approval applications.

  • author['full_name']

    Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined Ƶ in 2007.